Key result
Sertraline cuts dialysis-induced hypotension episodes by ~35% in hemodialysis patients.
Why the study?
Dialysis-induced hypotension affects 10-30% of hemodialysis sessions and increases mortality, but whether sertraline's modulation of the Bezold-Jarisch reflex safely and effectively prevents it remained to be systematically evaluated.
Does sertraline improve mean arterial pressure and prevent dialysis-induced hypotension in hemodialysis patients?
Does sertraline improve mean arterial pressure and prevent dialysis-induced hypotension in hemodialysis patients?
Sertraline significantly improves hemodynamic stability and reduces hypotension episodes during hemodialysis, offering a safe therapeutic option.
No takes yet. Share an insight, caveat, or question.
Offers clinicians a safe option for intradialytic hemodynamic instability; confirms efficacy via meta-analysis of hemodialysis patients.
Background/Objectives: Dialysis-induced hypotension (DIH) affects 10–30% of hemodialysis sessions and increases mortality. Sertraline may stabilize blood pressure by modulating the Bezold–Jarisch reflex. We aimed to evaluate the efficacy and safety of sertraline for preventing DIH. Methods: We searched PubMed, EMBASE, Cochrane Library, and ClinicalTrials.gov through December 2025. Random-effects meta-analysis was performed using standardized mean differences (SMD). Results: Nine studies (140 patients) met inclusion criteria. Sertraline significantly increased mean arterial pressure (SMD: 0.87; 95% CI: 0.52–1.22; p < 0.001), corresponding to approximately 8.5 mmHg. DIH episodes decreased by 35% (RR: 0.65; 95% CI: 0.48–0.88). Heterogeneity was moderate (I2 = 42%). Among studies reporting safety data (n = 106), adverse events were mild (14%) with no serious events. No publication bias was detected (Egger’s p = 0.21). Conclusions: Sertraline significantly improves hemodynamic stability during hemodialysis with a favorable safety profile. It represents a promising option for DIH, particularly in patients with comorbid depression or contraindications to midodrine.
Amer et al. (2026) studied this question. Sertraline reduced dialysis-induced hypotension episodes by 35% and increased mean arterial pressure by ~8.5 mmHg with mild adverse events in hemodialysis patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: